This approach has revealed insights into genes such as BRAF in melanoma and KRAS in pancreatic cancer.19, 20CRISPR–Cas9 allows researchers to investigate the functional relevance of potential drug targets in cancer cells. This evidence concerns the gene BRAF and melanoma.